Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
Votes to accept $2.8B plan
At least 100 killed in landslide
Arrested, charged w/ fraud
Alaska's rivers turn orange
'Quid pro quo' probe
Calls Trump claim dangerous
Mosby spared prison time
Police officer disciplined
Will miss her ninth Olympics
Harvard grads stage walkout
Planet parade 2024
Dow drops 600+points
Sued by cancer victims
Mahomes, Reid back Butker
Industry targeting youth
Werder leaving ESPN
Evans suffers minor stroke
Mortgage rates fall below 7%
Opposes tariffs on CN EVs
Expects a 2024 cash burn
La. criminalizes abortion pills
Warns of salmonella outbreak
To launch $5 value meal
Bill to prevent CBDCs
Cavaliers fire Bickerstaff
Limits state-affiliated media
Dow falls by over 600 points
Wade launches Translatable
Holds rally in South Bronx
OH gov. calls special session
To address Congress soon
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Moderna, FDA and RSV vaccine
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.
FDA delays decision on Moderna's RSV shot until the end of May
The FDA needs a few more weeks to decide the fate of Moderna's RSV vaccine, the company announced. A decision is now slated for the end of May, as opposed to May 12.
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Key Takeaways Moderna said the Food and Drug Administration (FDA) has delayed its approval decision for the respiratory syncytial virus (RSV) vaccine.The biotech reported it was advised by regulators that their review wouldn't be completed until the end of the month,
Yahoo Finance
13d
FDA delays decision on Moderna RSV vaccine
Moderna on Friday said the Food and
Drug
Administration has postponed an approval
decision
on its experimental
vaccine
for
respiratory syncytial virus
due to “administrative constraints ...
12h
on MSN
New COVID FLiRT variants spike as FDA delays key vaccine meeting
The FDA has delayed a key meeting to determine the formula for the next COVID-19 vaccines amid a spike in cases linked to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback